Brief: Rosetta Genomics receives U.S. patent for cancer of origin diagnostic assay
16/04/2015 14:15
April 16 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Receives key U.S. patent allowance for its cancer of origin diagnostic assay * Source text for Eikon ID:nBw11HLhya * Further company coverage ROSG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics